Intelligent Bio Solutions Expands European Market Presence with Innovative Fingerprint Drug Screening Technology’
In a pivotal move demonstrating its burgeoning influence in the field of non-invasive drug testing, Intelligent Bio Solutions Inc. (Nasdaq: INBS) has announced a significant new addition to its roster of clients. The company has forged a relationship with a major European transport and infrastructure solutions provider, underscoring its growing footprint across the continent. This partnership will see the deployment of INBS’s Intelligent Fingerprinting Drug Screening System within the United Kingdom operations of this transport leader, marking a crucial step forward in workplace drug testing and employee fitness monitoring.
Evolving Drug Testing: The Intelligent Fingerprinting Drug Screening System
The Intelligent Fingerprinting Drug Screening System represents a leap forward in drug testing technology, offering a rapid, non-invasive solution that leverages the unique capabilities of fingerprint sweat analysis. Unlike traditional methods, which can be intrusive and time-consuming, this innovative system allows for swift and reliable drug testing by analyzing minute amounts of sweat collected from a fingerprint. This system not only enhances the ease and speed of drug testing procedures but also ensures that the process is highly hygienic and virtually tamper-proof.
Quantifiable Benefits and Customer Satisfaction
The adoption of INBS’s cutting-edge technology is driven by the tangible benefits it delivers to businesses. Customers have reported myriad advantages, including greater in-house control over testing protocols, heightened project flexibility, and significant cost reductions. These benefits are particularly crucial in adapting to the evolving needs of modern workplaces, where ensuring employee safety and fitness for duty is paramount.
One clear testament to the efficacy and acceptance of this technology is its adoption by James Jones & Sons Ltd. a leading timber processor and packaging manufacturer in the UK. Operating across 25 sites and employing 1,300 individuals, James Jones & Sons Ltd. has integrated the Intelligent Fingerprinting Drug Screening System into its new drug and alcohol testing policy. By conducting in-house drug testing, the company maintains full control over the testing process, supporting its commitment to creating a safe and productive workplace.
Strategic Expansion and Market Confidence
The addition of a major European transport and infrastructure provider to its client base is not only a testament to the robustness of INBS’s technology but also a strategic milestone in the company’s expansion plans. This move exemplifies how the company is solidifying its presence in various industries, from transport and infrastructure to manufacturing and beyond.
The adoption of the Intelligent Fingerprinting Drug Screening System by large-scale operations, such as those of James Jones & Sons Ltd. serves to build market confidence in the technology. By showcasing real-world applications and benefits, INBS is setting a new standard in workplace drug testing, promoting both safety and efficiency.
The Future of Drug Testing Technology
As businesses across industries increasingly recognize the importance of maintaining a drug-free workplace, the demand for advanced testing solutions is surging. Intelligent Bio Solutions Inc. is at the forefront of this revolution, offering innovative, reliable, and user-friendly solutions that meet the stringent demands of modern business operations.
The company’s ongoing commitment to research and development ensures that it will continue to lead the charge in non-invasive drug testing technology, paving the way for broader adoption and integration across various sectors. With each new partnership and adoption, INBS is not just providing a service but also contributing to the overall enhancement of workplace safety standards globally.
Comments